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Nrf2 Deficiency Influences Susceptibility to Steroid Resistance
via HDAC2 reduction
David Adenuga, Samuel Caito, Hongwei Yao, Isaac K Sundar, Jae-Woong Hwang,
Sangwoon Chung, and Irfan Rahman*
Department of Environmental Medicine, Lung Biology and Disease Program, University of
Rochester Medical Center, Rochester, NY, USA
Abstract
Abnormal lung inflammation and oxidant burden are associated with a significant reduction in
histone deacetylase 2 (HDAC2) abundance and steroid resistance. We hypothesized that Nrf2
regulates steroid sensitivity via HDAC2 in response to inflammation in mouse lung. Furthermore,
HDAC2 deficiency leads to steroid resistance in attenuating lung inflammatory response, which
may be due to oxidant/antioxidant imbalance. Loss of antioxidant transcription factor Nrf2
resulted in decreased HDAC2 in lung, and increased inflammatory lung response which was not
reversed by steroid. Thus, steroid resistance or inability of steroids to control lung inflammatory
response is dependent on Nrf2-HDAC2 axis. These findings have implications in steroid
resistance, particularly during the conditions of oxidative stress when the lungs are more
susceptible to inflammatory response, which is seen in patients with chronic obstructive
pulmonary disease, asthma, rheumatoid arthritis, and inflammatory bowel disease.
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Introduction
Inhaled corticosteroids remain the therapy of choice for inflammatory diseases, such as
asthma and chronic obstructive pulmonary disease (COPD). However, inhaled or systemic
corticosteroids fail to attenuate chronic inflammation in these patients due to increased
oxidative stress [1–3]. Corticosteroids suppress inflammation by recruiting histone
deacetylase 2 (HDAC2) to NF-κB-driven pro-inflammatory gene promoters thereby
inhibiting the transcription of these genes [4]. Thus, the loss of corticosteroid ability to
suppress inflammation in COPD and asthma may be due to the loss of HDAC2 protein [5].
However, the mechanism for steroid resistance via HDAC2 reduction in oxidative stress-
prone condition in vivo is not known.
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Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) regulates the cellular antioxidant response
by upregulating genes involved in augmenting cellular antioxidant capacity and by inducing
the genes that detoxify reactive oxygen species or electrophilic compounds [6,7]. The level
of Nrf2 are decreased in conditions of oxidative stress [8–10], which accounts for persistent
and abnormal inflammation due to imbalance of oxidants/antioxidants in the lung [10–12].
Mice lacking Nrf2 gene are susceptible to cigarette smoke (CS)-induced pulmonary
inflammation and emphysema [13]. Hence, it is possible that abnormal inflammation seen in
these mice is oxidant-dependent and resistance to steroids perhaps due to oxidant-mediated
reduction in HDAC2 levels.
We hypothesized that Nrf2 regulates steroid sensitivity via HDAC2 in response to
inflammation in mouse lung. Furthermore, HDAC2 deficiency leads to steroid resistance in
attenuation of lung inflammatory response triggered by increased oxidative stress. We tested
this hypothesis in mice lacking Nrf2 and HDAC2 to determine the ability of corticosteroids
to inhibit lung inflammatory response induced by CS and LPS.
Materials and Methods
Materials
Unless otherwise stated, all biochemical reagents used in this study were purchased from
Sigma (St. Louis, MO). HDAC2 antibody was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). Monoclonal β-actin antibody was obtained from Calbiochem (La Jolla,
CA).
Mice
The Nrf2 knockout (KO) mouse strain (Nrf2−/− on C57BL/6J background) used in this
study is described earlier [5] and was generously supplied by Prof. Masayuki Yamamoto,
University of Tsukuba, Japan via the RIKEN BioResource Center, Tsukuba, Japan. HDAC2
mutant (HDAC2−/− on C57BL/6J background) mice were kindly provided by Dr. J.A.
Epstein (University of Pennsylvania School of Medicine, Philadelphia, PA) [14]. These
mice express a truncated and catalytically inactive form of HDAC2 with exons 9 – 14
replaced by a LacZ fusion gene created via a gene-trap method [14]. Wild-type (WT)
C57BL/6J mice were purchased from Jackson laboratories (Bar Harbor, ME). All animal
protocols for this study were approved by the University Committee on Animal Research of
the University of Rochester.
Cigarette smoke and lipopolysacharide (LPS) exposure to mice
Eight to ten week-old adult wild-type (WT), Nrf2−/− and HDAC2−/− were exposed to
diluted mainstream CS generated from 3R4F filtered research grade cigarettes as described
previously [15,16] for 1 h twice daily with 1 h interval in between for 3 days using a
Baumgartner-Jaeger CSM2072i cigarette smoke-generating machine (CH Technologies,
Westwood, NJ). Smoke concentration and airflow were adjusted to obtain a constant
particulate matter concentration of 300 mg/m3 total particulate matter (TPM) [15,16]. Mice
exposed to filtered air served as controls. Mice were sacrificed at 24 h post-last CS
exposure.
LPS exposure studies in mice were performed as described previously [17]. Briefly, age-
matched WT, Nrf2−/− and HDAC2−/− were exposed to aerosolized Escherichia coli LPS
(1 mg/ml) for 8 minutes. Aerosolized saline-exposed mice were used as controls, and
animals were sacrificed at 24 h post last exposure.
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Budesonide in dry-powered form was dissolved in 70% ethanol and then diluted with saline
prior to administration. Twenty-five microliters of budesonide solution, corresponding to 1
or 3 mg/kg body weight, was administered via an intranasal route to each mouse for 3 days
followed by LPS exposure at 1 h after last budesonide treatment [18].
Bronchoalveolar lavage
Mice were anaesthetized by pentobarbital (Abbott Laboratories, Abbott Park, IL)
intraperitoneal injection (100 mg/kg body weight) before sacrifice. Lungs were then
removed and lavaged three times with 0.6 ml of 0.9% sodium chloride with cannula inserted
into the trachea. Total lavage fluid for each mouse was combined and then centrifuged.
Supernatants were frozen at −80°C until required for further analysis and cell pellets
resuspended in 1 ml of saline, and total number of cells determined using a haemocytometer.
Differential counts (minimum 500 per slide) were determined using Diff-Quik (Dade
Behring, Newark, DE)-stained cytospin slides.
Lung tissue protein extraction
Cytoplasmic and nuclear proteins were extracted from frozen lung tissue samples as
described [19]. Whole cell lysate was extracted from lung tissue after homogenization in
RIPA buffer [15,16].
Immunoblotting
Protein estimation was performed by the bicinchoninic acid (BCA) method as described by
the manufacturer (Pierce, Rockford, IL). Mouse lung nuclear extracts (10 μg–20 μg) were
electrophoresed on 7.5% SDS-polyacrylamide gels, electro-blotted on PVDF membranes
(Millipore, Burlington, MA). Membranes were incubated with primary antibody in a 1:1000
dilution in 5% BSA in TBS. After extensive washing, primary antibodies were detected with
secondary antibodies linked to horse-radish peroxidase (Dako, Carpinteria, CA) and bound
complex detected with enhanced chemiluminescence (PerkinElmer, Waltham, MA).
Cytokine Analysis
Monocyte chemotactic protein 1 (MCP-1) levels were measured from mouse lung soluble
protein by enzyme-linked immunosorbent assay (ELISA) with the duo-antibody kit (R & D
Systems). Results were normalized to protein concentration per sample.
HDAC2 activity assay
HDAC2 was immunoprecipitated from lung homogenates (500 μg protein) by incubating
overnight with anti-HDAC2 antibody (2 μg). Beads were washed and incubated with Color
de Lys substrate (Biomol) for 80 minutes with rocking at 37 °C. 30 μL aliquots from each
sample were placed in 96-well plates and HDAC specific buffer added. Color de Lys
developer was then added and incubated for a further 20 minutes with rocking at 37 °C.
Color development was monitored at 405 nm. HDAC2 activity was expressed relative to
standard curve generated from 0 – 500 μM Color de Lys deacetylated standard.
Statistical analysis
Data expressed as mean±SEM. Statistical significance was calculated using one-way
Analysis of Variance (ANOVA) with STATVIEW software. NIH ImageJ software was used
for densitometry analysis. P<0.05 as significant compared to relative controls.
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HDAC2−/− mice are more susceptible to CS-induced lung inflammation
CS exposure induced neutrophil influx in bronchoalveolar lavage fluid (BALF) of WT mice,
which was significantly increased in HDAC2−/− mice (Fig. 1A). Consistent with this
finding, air- and CS-exposed HDAC2−/− mice showed significant increase in MCP-1, a
monocyte chemoattractant (Fig. 1B); and KC, a neutrophil chemoattractant (data not
shown), release in the lungs as compared to corresponding air- and CS- exposed WT mice,
suggesting the susceptibility of HDAC2 deficient mice to CS-induced lung inflammation.
HDAC2−/− mice are less responsive to budesonide in inhibiting LPS-induced lung
inflammation
LPS was used as a different lung inflammation-triggering agent rather than CS since
HDAC2 is inactivated and degraded in response to CS exposure both in mouse lungs in vivo,
and in epithelial cells and macrophages in vitro [19–22], whereas LPS aerosolization in WT
mice had no effect on HDAC2 protein levels in mouse lung (Figs. 2A and B). Not
surprisingly, neutrophil counts in BALF were significantly reduced in budesonide-pretreated
LPS-exposed WT mice as compared to saline-pretreated LPS-exposed WT mice (Fig. 2C).
Budesonide pretreatment had no effect on neutrophil counts in BALF of HDAC2−/− mice
(Fig. 2C). However, pretreatment of budesonide significantly lowered the MCP-1 (Fig. 2D)
and KC (data not shown) release in WT mouse lung in response to LPS exposure. The levels
of MCP-1 in lungs of HDAC2−/− mice were reduced by budesonide in response to LPS
exposure (Fig. 2D). However, the efficacy of budesonide in decreasing MCP-1 release in
HDAC2−/− mice (26.4%) was lower than that in WT mice (49.4%, P<0.01). Budesonide,
however, had no appreciable effect on KC release in response to LPS exposure in HDAC2−/
− mice (data not shown). Consistent with the MCP-1 and KC data, matrix metalloproteinase
9 (MMP9) activity was significantly elevated in HDAC2−/− mouse lungs compared to WT
lungs with only a minimal effect of budesonide treatment observed (data not shown).
Overall, these data suggest that HDAC2 deficiency leads to steroid insensitivity in terms of
attenuating lung inflammatory response.
Enhanced lung inflammation is associated with HDAC2 reduction in Nrf2−/− mice
exposed to CS
We determined whether mice deficient in the antioxidant transcription factor, Nrf2, would
be more susceptible to CS-mediated oxidative stress to cause lung inflammation. Neutrophil
influx, as a marker for increased vascular permeability and pulmonary inflammation, was
increased in lungs of Nrf2−/− mice as compared to WT mice in response to 3 days CS
exposure (Fig. 3A).
HDAC2 protein level and deacetylase activity are significantly decreased in response to CS-
mediated oxidative stress in mouse lungs [19], therefore, we speculated that HDAC2 protein
levels in lung may be altered in Nrf2−/− mice, which are susceptible to oxidative stress.
Naïve Nrf2−/− mouse lung showed decreased HDAC2 activity compared to WT mouse
lungs (Fig. 3B). To determine if this difference was due to accelerated loss of HDAC2
protein in lungs of Nrf2−/− mice, we compared HDAC2 protein abundance in nuclear
extracts of Nrf2−/− and WT mice. Consistent with reduction in HDAC2 activity, the
HDAC2 protein level was also significantly decreased in lung nuclear extracts of Nrf2−/−
mice as compared to WT mice in the absence of CS exposure (Figs. 3C and D). Three days
of CS exposure further decreased the levels of HDAC2 protein in Nrf2−/− mice compared
to WT mice (Figs. 3C and D). These results suggest that the loss of HDAC2 in Nrf2
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deficient mice is a crucial component of increased susceptibility to oxidative stress-induced
inflammatory response in the lungs.
Nrf2−/− mice are not responsive to budesonide in inhibiting LPS-induced lung
inflammation
Decreased HDAC2 protein levels and deacetylase activity in naïve Nrf2−/− mice suggested
that these mice may also exhibit resistance to steroid-mediated attenuation of lung
inflammation. As shown in Figure 2C, budesonide (3 mg/kg) pretreatment attenuated lung
neutrophil influx following LPS exposure by ~50% in WT mice. However, the neutrophils
influx in BALF was not altered by pretreatment of budesonide (1 and 3 mg/kg) in Nrf2−/−
mice in response to LPS exposure (Fig. 4A). Similarly, pretreatment of budesonide did not
reduce LPS-induced release of MCP-1 (Fig. 4B) and KC (data not shown) release in Nrf2−/
− mouse lung. These results suggest that the inability of steroids to inhibit lung
inflammation possibly be due to HDAC2 reduction in lungs of Nrf2 deficient mice.
Discussion
Although HDAC2 has been implicated in increased susceptibility to inflammation and
steroid resistance in vitro [21,23], no such studies are available to determine the role of
HDAC2 in vivo in lung in response to inhaled toxicants. In this study, we used mice
expressing mutant HDAC2 [14,24,25] to study the steroid resistance in response to CS
exposure. HDAC2−/− mice showed increased neutrophil recruitment in the lung in response
to CS as compared to WT mice exposed to CS. Neutrophil recruitment was correlated
strongly with the release of KC and MCP-1 in lung tissue suggesting the susceptibility of
these mice to augmentation of CS-induced inflammation.
Since CS induces degradation of other HDACs (HDAC1 and HDAC3) that may be crucial
for inflammation [21], it was important to determine a specific role for HDAC2 in steroid
resistance utilizing an exposure model with no effect on HDAC levels or activity. Hence, we
hypothesized that HDAC2−/− mice would exhibit a poor response to budesonide in
response to LPS exposure. As expected, budesonide had no significant effect in reducing KC
release in HDAC2−/− mice lungs in response to LPS. Furthermore, budesonide partially
blocked MCP-1 release in the lungs of HDAC2−/− mice versus complete inhibition of
MCP-1 in WT mice. Budesonide was also ineffective in reducing MMP9 activity in the
mutant mice. Thus, these data suggest that basal HDAC2 deficiency leads to increased
inflammatory response in the lung which is further augmented by LPS exposure.
Furthermore, steroids have poor efficacy in HDAC2-ablated mice in response to pro-
inflammatory challenge in the lung.
Increased susceptibility to oxidative stress (or deficiency of antioxidants) may exhibit
phenotypes similar to HDAC2−/− mice in terms of steroid resistance. We used Nrf2−/−
mice, which are susceptible to oxidative stress/cigarette smoke, to study the steroid
resistance in controlling the lung inflammatory response. Disruption of Nrf2 enhanced
susceptibility to acute CS-induced neutrophilic inflammation which is consistent with an
earlier report [13]. Surprisingly, in air-exposed Nrf2−/− mice, neutrophil infiltration and
RelA/p65 phosphorylation on ser276 and ser536 (unpublished data) were markedly
enhanced in the lungs. It is possible that loss of Nrf2 leads to activation of NF-κB by
increasing the pool of CREB-binding protein (CBP) available to interact with RelA/p65
[26,27], and thus causing induction of NF-κB-dependent pro-inflammatory genes. Our data
suggest that Nrf2 deficiency led to increased lung neutrophil influx and basal activation of
NF-κB, which are augmented by CS exposure.
Adenuga et al. Page 5













The finding that loss of Nrf2 induces an oxidative-stress phenotype in the lungs led us to
hypothesize that increased oxidative stress status of the lung in Nrf2−/− mice would induce
a reduction in HDAC2 activity and level. Lungs from naïve Nrf2−/− mice showed marked
reduction in HDAC2 abundance and subsequently reduced HDAC2 deacetylase activity
compared to naïve WT mice. Consistent with these data, exposure of Nrf2−/− mice to CS
rapidly accelerated the rate of HDAC2 degradation suggesting the oxidant burden in lungs
of Nrf2−/− is a key factor in loss of HDAC2 with or without exposure to environmental
toxicants. The reduction in levels of HDAC2 in Nrf2−/− mice alternatively suggests that
ARE-mediated Nrf2 activation may be required for HDAC2 transcription. However, the
molecular regulation of HDAC2 expression or transcription factor(s) binding site is not
clearly known [25]. It may also be possible that nuclear Nrf2 stabilizes the HDAC2 co-
repressor complex on pro-inflammatory genes, whereas deficiency of Nrf2 leads to
degradation of HDAC2 and activation of NF-κB-CBP binding on pro-inflammatory
promoters [26,27]. Our preliminary data support this contention showing activation of CBP
in lungs of Nrf2 null mice (unpublished data).
We next determined whether the increased inflammatory response and decreased HDAC2
protein levels in Nrf2−/− mice render them resistant to steroids in inhibiting the
inflammatory response. WT and Nrf2−/− mice were exposed to aerosolized LPS following
intranasal budesonide treatment. LPS induced severe neutrophilic inflammation in mouse
lungs (unlike macrophage influx by CS) with no subsequent reduction in HDAC2 protein
expression. Pre-treatment of WT mice with a high dose of budesonide significantly blocked
LPS-induced lung neutrophilic influx which is consistent with budesonide-mediated
inhibition of lung tissue KC levels. However, LPS-exposed Nrf2−/− mice failed to respond
to both low and high dose budesonide treatments in blocking neutrophil influx, attenuating
KC and MCP-1 release, and inhibiting RelA/p65 nuclear accumulation (unpublished data) in
the lung. The observation of steroid resistance in Nrf2−/− and HDAC2−/− mice with the
finding that HDAC2 protein levels are diminished in Nrf2−/− mice suggests a strong in vivo
linkage between HDAC2 abundance and steroid sensitivity via oxidative stress.
In conclusion, loss of HDAC2 is a critical factor in inhaled toxicant-mediated lung
inflammation especially in regulating the anti-inflammatory effects of glucocorticoids in
mouse lungs. Oxidative stress-susceptible Nrf2−/− mice showed reduced HDAC2 levels and
deacetylase activity in lungs, and are susceptible to CS- and LPS-induced inflammation.
Interestingly, the loss of Nrf2 potentially leads to steroid resistance due to HDAC2
reduction. We speculate that the high oxidant status in the lung of Nrf2−/− mice leads to
inactivation of endogenous HDAC2 through post-translational modifications, such as
nitrosylation of tyrosine residues and carbonylation of cysteine, histidine and lysine
residues. This may then block the ability of ligand-bound glucocorticoid receptors to recruit
active HDAC2 to promoters of pro-inflammatory genes. Nevertheless, the rapid loss of
HDAC2 and NF-κB activation in CS-exposed Nrf2−/− mice suggest steroid resistance is
clearly a multifactorial cascade of events that perhaps start with oxidant/antioxidant
imbalance and then precipitates at a much more rapid decline in HDAC2. This may have
implications for devising better therapies for patients who are refractory/insensitive to
steroid treatments, such as patients with COPD, asthma, rheumatoid arthritis, and
inflammatory bowel disease [5].
Research highlights
• HDAC2 is a critical factor in inhaled toxicant-mediated lung inflammation
especially in regulating the anti-inflammatory effects of glucocorticoids.
• Loss of Nrf2 resulted in decreased HDAC2 in lung, and increased inflammatory
lung response which was not reversed by steroid.
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• Steroid resistance or inability of steroids to control lung inflammatory response
is dependent on Nrf2-HDAC2 axis.
• Steroid resistance via Nrf2-HDAC2 axis leads to abnormal inflammatory
response which is seen in patients with chronic inflammatory diseases.
• Understanding the redox regulation of Nrf2-HDAC2 may lead to better
therapies for patients who are refractory/insensitive to steroid treatments.
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Fig. 1. HDAC2−/− mice are more susceptible to CS-induced lung inflammation
WT and HDAC2−/− mice were exposed to filtered air or acute CS for 3 days. Mice were
sacrificed at 24 h post-last exposure, and lungs were lavaged. Bronchoalveolar lavage cells
were prepared on cytospin slides and stained with Diff-Quik. (A) Total number of
neutrophils in BALF. (B) MCP-1 levels were measured in mouse lung tissue by ELISA.
Data are shown as mean±SEM (n=4 to 6). *P<0.05, **P<0.01, ***P<0.001 significant
compared with corresponding air groups. #P<0.05, and ###P<0.001 compared with
corresponding WT mice exposed to CS. $P<0.05, compared with air-exposed WT mice.
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Fig. 2. HDAC2−/− mice are less responsive to budesonide in response to LPS-induced lung
inflammation
(A) WT mice were exposed to saline or aerosolized LPS (1 mg/ml). Nuclear extracts from
mouse lungs were separated on SDS-PAGE gel, and HDAC2 protein levels were determined
by immunoblotting. (B) Band intensity of HDAC2 levels normalized to actin. (C and D) WT
and HDAC2−/− mice were pretreated with budesonide (3 mg/kg body weight) for 3 days at
1 h prior to aerosolization of LPS. (C) Neutrophils in BALF were determined following
differential staining on cytospin slides. (D) MCP-1 levels were measured from lung
homogenates of mouse lung tissue by ELISA. Data are shown as mean±SEM (n=4 to 6).
***P<0.001, significant compared with corresponding controls as denoted in figure. Sal:
Saline; Bud: Budesonide.
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Fig. 3. Increased lung inflammation is associated with HDAC2 reduction in Nrf2−/− mice
exposed to CS
(A) WT and Nrf2−/− mice were exposed to CS for 3 days. Differential counts from BALF
were determined by Diff-Quik staining of cytospin slides. (B) Immunoprecipitated HDAC2
from lungs of naïve WT and Nrf2−/− mice were analyzed for deacetylase activity using
specific HDAC deacetylase activity kit. (C) WT and Nrf2−/− mice were exposed to filtered
air or whole body CS for 3 days. Lung tissue nuclear extracts were analyzed for HDAC2
relative expression. (D) HDAC2 levels normalized to actin expression. Data are shown as
mean±SEM (n=4 to 9). *P<0.05, **P<0.01, and ***P<0.001, significant compared with
corresponding air-exposed controls. #P<0.05 and ###P<0.001, significant compared with
CS-exposed WT controls. $$$P<0.001, compared with air-exposed WT mice.
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Fig. 4. Nrf2−/− mice are unresponsive to budesonide following LPS exposure
Nrf2−/− mice were treated with budesonide (1 or 3 mg/kg body weight) by intranasal
administration followed by LPS exposure. (A) Percentage of neutrophils in BALF was
determined following differential staining on cytospin slides. (B) MCP-1 levels were
measured in lung tissue homogenates by ELISA. Data are shown as mean±SEM (n=4 to 6).
***P<0.001 significant compared with corresponding controls. Sal: Saline; Bud:
Budesonide.
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